These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28105988)

  • 1. National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014.
    Hauser A; Hofmann A; Hanke K; Bremer V; Bartmeyer B; Kuecherer C; Bannert N
    Euro Surveill; 2017 Jan; 22(2):. PubMed ID: 28105988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America.
    Holguín Á; Yebra G; Martín L; de Pineda AT; Ruiz LE; Quezada AY; Nieto AI; Escobar G
    Clin Microbiol Infect; 2013 Dec; 19(12):E523-32. PubMed ID: 23782115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses.
    Hauser A; Hofmann A; Meixenberger K; Altmann B; Hanke K; Bremer V; Bartmeyer B; Bannert N
    PLoS One; 2018; 13(11):e0206234. PubMed ID: 30408827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program.
    Jayaraman GC; Archibald CP; Kim J; Rekart ML; Singh AE; Harmen S; Wood M; Sandstrom P
    J Acquir Immune Defic Syndr; 2006 May; 42(1):86-90. PubMed ID: 16763495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.
    Lunar MM; Židovec Lepej S; Tomažič J; Vovko TD; Pečavar B; Turel G; Maver M; Poljak M
    PLoS One; 2018; 13(4):e0196670. PubMed ID: 29698470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.
    de Mulder M; York VA; Wiznia AA; Michaud HA; Nixon DF; Holguin A; Rosenberg MG
    HIV Med; 2014 Mar; 15(3):135-43. PubMed ID: 24112468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
    Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
    J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.
    Zhang J; Guo Z; Yang J; Pan X; Jiang J; Ding X; Zhang W; Xia Y; Xu Y; Huang J
    J Med Virol; 2015 Oct; 87(10):1668-76. PubMed ID: 25899877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survey of HIV-1 drug resistance threshold in Shandong Province in 2013-2015].
    Sun XG; Yu HY; Su SL; Lin B; Li JH; Lin L; Tao XR; Qian YS; Kang DM; Xing H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):604-609. PubMed ID: 28693084
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
    Riva C; Lai A; Caramma I; Corvasce S; Violin M; Dehò L; Prati F; Rossi C; Colombo MC; Capetti A; Franzetti M; Rossini V; Tambussi G; Ciccozzi M; Suligoi B; Mussini C; Rezza G; Balotta C
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):41-9. PubMed ID: 20055587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
    de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
    Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of drug resistance in therapy-naïve HIV infected patients and detection of African HIV subtypes in Hungary.
    Kanizsai S; Ghidán A; Ujhelyi E; Bánhegyi D; Nagy K
    Acta Microbiol Immunol Hung; 2010 Mar; 57(1):55-68. PubMed ID: 20350879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007.
    Hurt CB; McCoy SI; Kuruc J; Nelson JA; Kerkau M; Fiscus S; McGee K; Sebastian J; Leone P; Pilcher C; Hicks C; Eron J
    Antivir Ther; 2009; 14(5):673-8. PubMed ID: 19704170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India.
    Nesakumar M; Haribabu H; Cheedarla N; Karunaianantham R; Kailasam N; Sathyamurthi P; Selvachithiram M; Tripathy SP; Hanna LE
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):775-779. PubMed ID: 31001987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.